Search

everythinglearnresearchcommunity

for

Search:↓

Fulvestrant solution doesn't help hair loss in men and postmenopausal women.

Ethinylestradiol/chlormadinone acetate may be an effective and well-tolerated treatment for skin conditions caused by excess androgens.

The document concludes that managing PCOS requires a comprehensive approach, including lifestyle changes and medication, to improve symptoms and reduce health risks.

Herbal hair scrubs can effectively prevent and treat hair problems, boosting self-confidence.

About 40% of women by age 60 experience significant hair loss, often due to androgenetic alopecia, with treatments like minoxidil available and hope for future cures.

Androstenedione is better than testosterone for diagnosing PCOS in Indian women.

Cyclosporine starts hair growth faster, while minoxidil makes it last longer.

Prolactin may play a significant role in skin and hair health and could be a target for treating skin and hair disorders.

Trichoscopy is good for diagnosing and monitoring hair and scalp problems in children but needs more research for certain conditions.

Baldness at age 40 is not linked to a higher risk of aggressive prostate cancer.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

The conclusion is that treatments like finasteride and minoxidil can prevent baldness progression and improve hair density, but more research is needed on other therapies.

Hair density and thickness decrease in all scalp areas for East Asians with AGA.

Hair loss patterns are linked to temperament and can help diagnose it.

PCOS is a complex condition that can lead to serious health issues, but early diagnosis and treatment can reduce these risks.

PCOS is a genetic disorder affecting women's reproductive health, with treatments focused on symptoms like insulin resistance and fertility.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

Human skin makes sexual hormones that affect hair growth, skin health, and healing; too much can cause acne and hair loss, while treatments can manage these conditions.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

Women with PCOS face higher risks of diabetes and heart disease, and these risks increase with obesity.

Too much androgen can cause hair loss; finasteride may help.

The telogen phase of hair growth is active and important for preparing hair follicles for regeneration, not just a resting stage.

Hair shedding is an active process that could be targeted to treat hair loss.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

HFMs can help study hair growth and test potential hair growth drugs.

The document explains how the male reproductive system works, its role in making testosterone, and how conditions like obesity can disrupt it, leading to low testosterone and fertility issues.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

Black ethnicity, prior PSA tests, enlarged prostate, and family history increase prostate cancer risk; Asian ethnicity, obesity, smoking, diabetes, and less sexual activity or no children decrease risk.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

PRP treatment helps hair growth in most cases, but more research needed.